These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 33748924)

  • 1. Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2.
    Hang W; Chen C; Zhang XA; Wang DW
    Front Med; 2021 Aug; 15(4):638-643. PubMed ID: 33748924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
    Pons S; Fodil S; Azoulay E; Zafrani L
    Crit Care; 2020 Jun; 24(1):353. PubMed ID: 32546188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
    Amraei R; Rahimi N
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Sepsis.
    Koçak Tufan Z; Kayaaslan B; Mer M
    Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
    Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
    Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
    Bernard I; Limonta D; Mahal LK; Hobman TC
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19.
    Zhang J; McCullough PA; Tecson KM
    Rev Cardiovasc Med; 2020 Sep; 21(3):339-344. PubMed ID: 33070539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial inflammation and dysfunction in COVID-19.
    Sbirkov Y; Dzharov V; Todorova K; Hayrabedyan S; Sarafian V
    Vasa; 2022 Mar; 51(2):62-70. PubMed ID: 35171039
    [No Abstract]   [Full Text] [Related]  

  • 13. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe COVID-19 and aging: are monocytes the key?
    Pence BD
    Geroscience; 2020 Aug; 42(4):1051-1061. PubMed ID: 32556942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunology and immunotherapy for COVID-19.
    Liu Y; Zhou X; Liu X; Jiang X
    Expert Rev Mol Med; 2021 Dec; 23():e24. PubMed ID: 34915958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.
    Gavriilaki E; Anyfanti P; Gavriilaki M; Lazaridis A; Douma S; Gkaliagkousi E
    Curr Hypertens Rep; 2020 Aug; 22(9):63. PubMed ID: 32852642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Dysfunction in Covid-19 Infection.
    Otifi HM; Adiga BK
    Am J Med Sci; 2022 Apr; 363(4):281-287. PubMed ID: 35093394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endotheliitis in COVID-19].
    Varga Z
    Pathologe; 2020 Dec; 41(Suppl 2):99-102. PubMed ID: 33306138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.